Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
archive
research
articles containing video clips
colloids
dosage forms
drug delivery devices
gels
histopathology
infectious causes of cancer
male genital neoplasia
medical
neoplastic and hyperplastic prostate disorders
physical chemistry
prostate cancer
rtt
companies based in minneapolis
companies established in 1895
companies listed on the new york stock exchange
investment banks
minnesota
study
u.s. bancorp
What
prostate
13
×
risk
13
×
absorbable
augmenix
company
develops
hydrogels
manufactures
medical
organs
press
proprietary
protect
radiotherapy
release
sells
separate
technology
announced
cancer
today
hydrogel
announces
spaceoar
annual
conference
healthcare
present
radiation
treated
treatment
commonly
data
developing
drugs
increased
international
j.p
morgan
new
Language
unset
Current search:
prostate
×
risk
×
@slashgear.com
4 years ago
Low-risk ultrasound procedure revolutionizes prostate cancer treatment
@slashgear.com
4 years ago
Study finds link between prostate cancer therapy and dementia risk
@slashgear.com
5 years ago
Common prostate drugs linked to diabetes: What you need to know
@venturebeat.com
6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
6 years ago
Augmenix Partners with Us TOO International to Stream Live Webcast and Q & A on Prostate Cancer Radiation Therapy
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30